Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia

2001/06/01 by David P Nicolau, David P. Nicolau, JoCarol McNabb +5 · 26 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Antibiotics Pharmacokinetics and Efficacy #Antibiotic Resistance in Bacteria #Pneumonia and Respiratory Infections

paper · doi:10.1016/s0924-8579(01)00329-6

Cited by

• Meta-analysis on safety of standard vs. prolonged infusion of beta-lactams
• Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation. [europepmc]
• Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy. [europepmc]
• Pharmacodynamic optimization of beta-lactams in the patient care setting. [europepmc]
• Does prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials. [europepmc]
• Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial. [europepmc]
• Continuous infusion of antibiotics in the critically ill: The new holy grail for beta-lactams and vancomycin? [europepmc]
• Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review. [europepmc]
• Continuous beta-lactam infusion in critically ill patients: the clinical evidence. [europepmc]
• Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections. [europepmc]
• Optimal dosing of antibiotics in critically ill patients by using continuous/extended infusions: a systematic review and meta-analysis. [europepmc]
• Clinical pharmacodynamics of antipseudomonal cephalosporins in patients with ventilator-associated pneumonia. [europepmc]
• Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. [europepmc]
• Lung concentrations of ceftazidime administered by continuous versus intermittent infusion in patients with ventilator-associated pneumonia. [europepmc]
• Continuous and Prolonged Intravenous β-Lactam Dosing: Implications for the Clinical Laboratory. [europepmc]
• Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients. [europepmc]
• Calculated initial parenteral treatment of bacterial infections: Pharmacokinetics and pharmacodynamics. [europepmc]
• Prolonged versus intermittent β-lactam antibiotics intravenous infusion strategy in sepsis or septic shock patients: a systematic review with meta-analysis and trial sequential analysis of randomized trials. [europepmc]
• Optimizing Antimicrobial Drug Dosing in Critically Ill Patients. [europepmc]
• Antibiotics in Necrotizing Soft Tissue Infections. [europepmc]
• Dose optimization of β-lactams antibiotics in pediatrics and adults: A systematic review. [europepmc]
• Optimizing Betalactam Clinical Response by Using a Continuous Infusion: A Comprehensive Review. [europepmc]
• Efficacy of Continuous vs. Intermittent Administration of Cefepime in Adult ICU Patients with Gram-Negative Bacilli Bacteremia: A Randomized Double-Blind Clinical Study. [europepmc]
• Extended-Infusion β-Lactam Therapy, Mortality, and Subsequent Antibiotic Resistance Among Hospitalized Adults With Gram-Negative Bloodstream Infections. [europepmc]
• Vitamins Can Increase Antibiotic Effects Against Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii in an In Vitro Infection Model. [europepmc]
• The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024. [europepmc]